This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help regulate blood sugar and suppress appetite. These drugs have become popular for their effectiveness ...

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

“Following higher-than-expected volume growth in recent years, including GLP-1-based products such as Ozempic and Wegovy, combined with the expectation of continued volume growth and capacity ...

This puts a major focus on Ozempic and Wegovy, which combined with other GLP-1 products account for over 42% of sales for Novo. The worry now is that generic versions sold by Hims & Hers could ...